1035 Cambridge Street
Suite 18A
Cambridge, MA 02141
United States
212 582 1199
https://eternatx.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 8
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Ms. Sandra M. Gurrola | Principal Financial & Accounting Officer and Senior VP of Finance | 305.88k | N/A | 1967 |
Mr. Sanjeev Luther | CEO, President & Director | N/A | N/A | 1962 |
Ms. Dorothy J. Clarke | General Counsel & Director | N/A | N/A | 1966 |
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Eterna Therapeutics Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.